期刊
EUROPEAN JOURNAL OF CANCER PREVENTION
卷 30, 期 4, 页码 311-314出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CEJ.0000000000000624
关键词
hereditary breast cancer; BRCA guidelines; clinical implication
类别
资金
- Italian Ministry of Health with Ricerca Corrente and 5x1000 funds
Scientific research on the risk of breast cancer in the context of hereditary breast cancer syndrome is constantly evolving, requiring a multidisciplinary approach based on updated guidelines. The recent Expert Panel Consensus provides accurate treatment directions for patients with specific genetic mutations, serving as a valuable tool for physicians in daily practice.
Scientific acquisitions concerning the risk of breast cancer in the context of hereditary breast cancer syndrome are constantly evolving: alongside the BRCA1 and BRCA2 mutations, further ones have been identified, also associated with malignancies in different sites. Therefore, management of these clinical conditions requires a multidisciplinary and shared approach, based on constantly updated guidelines. The recent Expert Panel Consensus about management of hereditary breast cancer, chaired by the Society of Surgical Oncology with the American Society of Clinical Oncology and the American Society of Radiation Oncology, based on the evidences obtained by a systematic review of the literature, delineate accurate and novel directions towards an appropriate surgical, radiation, and systemic therapy management of breast cancer patients with specific germline mutations. These recent recommendations will provide to physicians an updated and useful tool in treatment decision making of these patients in daily practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据